CureVac Net Receivables vs Property Plant Equipment Analysis

CVAC Stock

USD 2.65 0.13 5.16%

CureVac NV financial indicator trend analysis is way more than just evaluating CureVac NV prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether CureVac NV is a good investment. Please check the relationship between CureVac NV Net Receivables and its Property Plant Equipment accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CureVac NV. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.

For information on how to trade CureVac Stock refer to our How to Trade CureVac Stock guide.

Net Receivables vs Property Plant Equipment

Net Receivables vs Property Plant Equipment Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of CureVac NV Net Receivables account and Property Plant Equipment. At this time, the significance of the direction appears to have very strong relationship.

The correlation between CureVac NV's Net Receivables and Property Plant Equipment is 0.83. Overlapping area represents the amount of variation of Net Receivables that can explain the historical movement of Property Plant Equipment in the same time period over historical financial statements of CureVac NV, assuming nothing else is changed. The correlation between historical values of CureVac NV's Net Receivables and Property Plant Equipment is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Receivables of CureVac NV are associated (or correlated) with its Property Plant Equipment. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Property Plant Equipment has no effect on the direction of Net Receivables i.e., CureVac NV's Net Receivables and Property Plant Equipment go up and down completely randomly.

Correlation Coefficient

0.83

Relationship Direction	Positive
Relationship Strength	Strong

View All Relationships

Net Receivables

Property Plant Equipment

Most indicators from CureVac NV's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into CureVac NV current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CureVac NV. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.

For information on how to trade CureVac Stock refer to our How to Trade CureVac Stock guide.At present, CureVac NV's Sales General And Administrative To Revenue is projected to slightly decrease based on the last few years of reporting.

	2021	2022	2023	2024 (projected)
Depreciation And Amortization	25.8M	26.4M	26.7M	19.2M
Interest Income	10.1M	4.0M	12.9M	13.6M

Depreciation And Amortization Interest Income

CureVac NV fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Deferred Long Term Liab
Total Assets		0.8	0.94	0.98	0.75	0.97	0.72	0.92	-0.97	-0.67	0.69	0.98	0.72	-0.25	-0.34	0.98	0.41	0.91	-0.1	-0.8	0.76	0.77	0.91	0.39	0.96	-0.32
Other Current Liab	0.8		0.96	0.85	0.3	0.86	0.75	0.57	-0.72	-0.69	0.92	0.74	0.74	-0.31	-0.4	0.73	0.46	0.8	0.26	-0.69	0.29	0.97	0.86	0.24	0.69	-0.49
Total Current Liabilities	0.94	0.96		0.96	0.52	0.95	0.77	0.76	-0.88	-0.71	0.87	0.89	0.76	-0.27	-0.38	0.89	0.45	0.89	0.09	-0.77	0.53	0.93	0.93	0.29	0.85	-0.43
Total Stockholder Equity	0.98	0.85	0.96		0.62	1.0	0.82	0.84	-0.92	-0.77	0.78	0.93	0.82	-0.31	-0.45	0.93	0.53	0.95	0.05	-0.79	0.63	0.83	0.86	0.38	0.9	-0.47
Other Liab	0.75	0.3	0.52	0.62		0.61	0.18	0.95	-0.84	-0.2	0.06	0.84	0.19	-0.09	0.03	0.85	-0.13	0.53	-0.56	-0.49	0.96	0.18	0.71	0.49	0.87	0.21
Net Tangible Assets	0.97	0.86	0.95	1.0	0.61		0.84	0.83	-0.91	-0.77	0.77	0.92	0.84	-0.34	-0.47	0.91	0.54	0.95	0.08	-0.79	0.61	0.83	0.85	0.4	0.88	-0.48
Property Plant And Equipment Net	0.72	0.75	0.77	0.82	0.18	0.84		0.45	-0.55	-0.96	0.79	0.59	1.0	-0.55	-0.78	0.57	0.9	0.9	0.58	-0.8	0.21	0.8	0.49	0.4	0.54	-0.8
Current Deferred Revenue	0.92	0.57	0.76	0.84	0.95	0.83	0.45		-0.96	-0.42	0.36	0.97	0.45	-0.16	-0.12	0.97	0.11	0.74	-0.39	-0.67	0.93	0.48	0.86	0.47	0.98	0.0
Net Debt	-0.97	-0.72	-0.88	-0.92	-0.84	-0.91	-0.55	-0.96		0.48	-0.56	-0.99	-0.55	0.07	0.12	-0.99	-0.19	-0.78	0.33	0.68	-0.85	-0.65	-0.93	-0.3	-0.98	0.1
Retained Earnings	-0.67	-0.69	-0.71	-0.77	-0.2	-0.77	-0.96	-0.42	0.48		-0.72	-0.54	-0.96	0.72	0.9	-0.53	-0.87	-0.92	-0.64	0.79	-0.18	-0.74	-0.44	-0.57	-0.51	0.86
Accounts Payable	0.69	0.92	0.87	0.78	0.06	0.77	0.79	0.36	-0.56	-0.72		0.58	0.78	-0.19	-0.45	0.57	0.62	0.75	0.37	-0.63	0.1	0.98	0.66	0.0	0.52	-0.65
Cash	0.98	0.74	0.89	0.93	0.84	0.92	0.59	0.97	-0.99	-0.54	0.58		0.59	-0.15	-0.2	1.0	0.25	0.83	-0.26	-0.74	0.85	0.68	0.93	0.37	0.99	-0.16
Non Current Assets Total	0.72	0.74	0.76	0.82	0.19	0.84	1.0	0.45	-0.55	-0.96	0.78	0.59		-0.55	-0.78	0.57	0.9	0.91	0.57	-0.79	0.22	0.79	0.48	0.4	0.54	-0.8
Non Currrent Assets Other	-0.25	-0.31	-0.27	-0.31	-0.09	-0.34	-0.55	-0.16	0.07	0.72	-0.19	-0.15	-0.55		0.89	-0.14	-0.5	-0.56	-0.68	0.39	0.07	-0.26	-0.13	-0.89	-0.14	0.68
Other Assets	-0.34	-0.4	-0.38	-0.45	0.03	-0.47	-0.78	-0.12	0.12	0.9	-0.45	-0.2	-0.78	0.89		-0.19	-0.81	-0.7	-0.8	0.53	0.11	-0.45	-0.1	-0.67	-0.17	0.91
Cash And Short Term Investments	0.98	0.73	0.89	0.93	0.85	0.91	0.57	0.97	-0.99	-0.53	0.57	1.0	0.57	-0.14	-0.19		0.22	0.82	-0.28	-0.72	0.85	0.66	0.93	0.37	0.99	-0.15
Net Receivables	0.41	0.46	0.45	0.53	-0.13	0.54	0.9	0.11	-0.19	-0.87	0.62	0.25	0.9	-0.5	-0.81	0.22		0.68	0.75	-0.69	-0.05	0.58	0.1	0.26	0.22	-0.82
Common Stock Total Equity	0.91	0.8	0.89	0.95	0.53	0.95	0.9	0.74	-0.78	-0.92	0.75	0.83	0.91	-0.56	-0.7	0.82	0.68		0.29	-0.85	0.51	0.8	0.73	0.56	0.8	-0.66
Common Stock Shares Outstanding	-0.1	0.26	0.09	0.05	-0.56	0.08	0.58	-0.39	0.33	-0.64	0.37	-0.26	0.57	-0.68	-0.8	-0.28	0.75	0.29		-0.27	-0.59	0.34	-0.23	0.3	-0.29	-0.79
Short Term Investments	-0.8	-0.69	-0.77	-0.79	-0.49	-0.79	-0.8	-0.67	0.68	0.79	-0.63	-0.74	-0.79	0.39	0.53	-0.72	-0.69	-0.85	-0.27		-0.56	-0.72	-0.64	-0.44	-0.77	0.4
Non Current Liabilities Total	0.76	0.29	0.53	0.63	0.96	0.61	0.21	0.93	-0.85	-0.18	0.1	0.85	0.22	0.07	0.11	0.85	-0.05	0.51	-0.59	-0.56		0.21	0.68	0.32	0.89	0.27
Inventory	0.77	0.97	0.93	0.83	0.18	0.83	0.8	0.48	-0.65	-0.74	0.98	0.68	0.79	-0.26	-0.45	0.66	0.58	0.8	0.34	-0.72	0.21		0.77	0.12	0.63	-0.58
Other Current Assets	0.91	0.86	0.93	0.86	0.71	0.85	0.49	0.86	-0.93	-0.44	0.66	0.93	0.48	-0.13	-0.1	0.93	0.1	0.73	-0.23	-0.64	0.68	0.77		0.29	0.91	-0.1
Other Stockholder Equity	0.39	0.24	0.29	0.38	0.49	0.4	0.4	0.47	-0.3	-0.57	0.0	0.37	0.4	-0.89	-0.67	0.37	0.26	0.56	0.3	-0.44	0.32	0.12	0.29		0.39	-0.36
Total Liab	0.96	0.69	0.85	0.9	0.87	0.88	0.54	0.98	-0.98	-0.51	0.52	0.99	0.54	-0.14	-0.17	0.99	0.22	0.8	-0.29	-0.77	0.89	0.63	0.91	0.39		-0.09
Deferred Long Term Liab	-0.32	-0.49	-0.43	-0.47	0.21	-0.48	-0.8	0.0	0.1	0.86	-0.65	-0.16	-0.8	0.68	0.91	-0.15	-0.82	-0.66	-0.79	0.4	0.27	-0.58	-0.1	-0.36	-0.09

Click cells to compare fundamentals

CureVac NV Account Relationship Matchups

CureVac NV fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	130.6M	1.5B	1.2B	860.5M	788.9M	838.8M
Other Current Liab	13.3M	68.8M	176.3M	46.2M	90.5M	74.8M
Total Current Liabilities	28.1M	247.6M	357.7M	156.2M	186.5M	184.1M
Total Stockholder Equity	(42.8M)	711.3M	688.5M	533.3M	517.4M	447.3M
Net Tangible Assets	(48.2M)	697.9M	676.2M	501.5M	576.7M	407.8M
Property Plant And Equipment Net	66.8M	104.8M	200.4M	241.7M	278.9M	172.0M
Current Deferred Revenue	7.5M	158.0M	55.8M	36.8M	44.6M	56.5M
Net Debt	48.5M	(1.3B)	(782.6M)	(453.7M)	(360.9M)	(379.0M)
Retained Earnings	(515.9M)	(645.1M)	(1.1B)	(1.3B)	(1.6B)	(1.5B)
Accounts Payable	5.3M	17.6M	122.3M	68.2M	46.4M	49.3M
Cash	30.7M	1.3B	811.5M	495.8M	402.8M	565.5M
Non Current Assets Total	73.4M	121.5M	218.2M	276.4M	310.1M	192.9M
Non Currrent Assets Other	967K	1.1M	1.2M	1.7M	(14.2M)	(13.5M)
Other Assets	6.3M	7.5M	5.6M	3.0M	1.0	0.95
Cash And Short Term Investments	32.1M	1.3B	816.1M	500.3M	402.8M	575.1M
Net Receivables	17.7M	1.8M	18.5M	39.4M	35.9M	22.0M
Common Stock Shares Outstanding	186.9M	132.2M	186.0M	189.1M	220.8M	200.0M
Short Term Investments	1.5M	2.6M	4.6M	4.5M	2.7M	2.5M
Liabilities And Stockholders Equity	130.6M	1.5B	1.2B	860.5M	788.9M	838.8M
Non Current Liabilities Total	145.3M	552.4M	112.0M	171.0M	85.0M	150.8M
Capital Lease Obligations	14.1M	55.3M	28.9M	42.1M	41.8M	33.4M
Inventory	6.2M	14.5M	56.2M	24.0M	24.8M	23.6M
Other Current Assets	1.2M	48.3M	49.2M	5.3M	15.2M	22.3M
Other Stockholder Equity	493.4M	1.4B	(5.8M)	(1.5M)	2.1B	2.2B
Total Liab	173.4M	800.0M	469.8M	327.2M	271.5M	391.5M
Deferred Long Term Liab	966K	1.0M	515K	302K	271.8K	258.2K
Net Invested Capital	22.2M	711.3M	688.5M	533.3M	516.9M	459.1M
Property Plant And Equipment Gross	61.7M	104.8M	247.4M	258.7M	301.8M	186.0M
Total Current Assets	57.2M	1.4B	940.0M	584.0M	478.8M	645.9M
Accumulated Other Comprehensive Income	472.4M	1.3B	1.7B	1.8B	(67.1K)	(63.7K)
Non Current Liabilities Other	529K	284K	264K	19K	17.1K	16.2K
Net Working Capital	29.1M	1.1B	582.3M	427.8M	292.0M	461.7M
Short Term Debt	2.0M	3.2M	3.5M	5.0M	5.0M	3.5M
Intangible Assets	5.7M	14.1M	13.2M	19.3M	15.9M	13.7M

Pair Trading with CureVac NV

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CureVac NV position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CureVac NV will appreciate offsetting losses from the drop in the long position's value.

Moving together with CureVac Stock

0.91

EVOK

Evoke Pharma

Pair Corr

Moving against CureVac Stock

0.73	JAGX	Jaguar Animal Health Financial Report 20th of May 2024	Pair Corr
0.65	ELYM	Eliem Therapeutics Trending	Pair Corr
0.54	OGN	Organon	Pair Corr
0.51	IBIO	Ibio Inc	Pair Corr
0.49	VKTX	Viking Therapeutics	Pair Corr

The ability to find closely correlated positions to CureVac NV could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CureVac NV when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CureVac NV - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CureVac NV to buy it.

The correlation of CureVac NV is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CureVac NV moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CureVac NV moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for CureVac NV can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether CureVac NV offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of CureVac NV's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Curevac Nv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Curevac Nv Stock:

How To Invest In CureVac

Details

Is CureVac Stock a good investment?

Details

What is CureVac NV's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CureVac NV. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.

For information on how to trade CureVac Stock refer to our How to Trade CureVac Stock guide.

Note that the CureVac NV information on this page should be used as a complementary analysis to other CureVac NV's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Complementary Tools for CureVac Stock analysis

When running CureVac NV's price analysis, check to measure CureVac NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CureVac NV is operating at the current time. Most of CureVac NV's value examination focuses on studying past and present price action to predict the probability of CureVac NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CureVac NV's price. Additionally, you may evaluate how the addition of CureVac NV to your portfolios can decrease your overall portfolio volatility.

	Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities
	Fundamental Analysis View fundamental data based on most recent published financial statements
	Technical Analysis Check basic technical indicators and analysis based on most latest market data
	Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets
	Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
	Economic Indicators Top statistical indicators that provide insights into how an economy is performing
	My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
	Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges
	Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences
	AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities
	Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals

Is CureVac NV's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CureVac NV. If investors know CureVac will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CureVac NV listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.26)

Revenue Per Share

0.243

Quarterly Revenue Growth

0.931

Return On Assets

(0.21)

Return On Equity

(0.50)

The market value of CureVac NV is measured differently than its book value, which is the value of CureVac that is recorded on the company's balance sheet. Investors also form their own opinion of CureVac NV's value that differs from its market value or its book value, called intrinsic value, which is CureVac NV's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CureVac NV's market value can be influenced by many factors that don't directly affect CureVac NV's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between CureVac NV's value and its price as these two are different measures arrived at by different means. Investors typically determine if CureVac NV is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CureVac NV's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

CureVac Net Receivables vs Property Plant Equipment Analysis

Net Receivables vs Property Plant Equipment

Net Receivables vs Property Plant Equipment Correlation Analysis

Correlation Coefficient

Net Receivables

Property Plant Equipment

CureVac NV fundamental ratios Correlations

CureVac NV Account Relationship Matchups

High Positive Relationship

High Negative Relationship

CureVac NV fundamental ratios Accounts

Pair Trading with CureVac NV

Moving together with CureVac Stock

Moving against CureVac Stock

Complementary Tools for CureVac Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Tangible Assets	+ 1.0	Total Stockholder Equity
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Cash And Short Term Investments	+ 1.0	Cash
Total Liab	+ 0.99	Cash
Total Liab	+ 0.99	Cash And Short Term Investments
Total Stockholder Equity	+ 0.98	Total Assets

Cash And Short Term Investments	- 0.99	Net Debt
Cash	- 0.99	Net Debt
Total Liab	- 0.98	Net Debt
Net Debt	- 0.97	Total Assets
Non Current Assets Total	- 0.96	Retained Earnings
Net Debt	- 0.96	Current Deferred Revenue